Published on 11 Dec 2023 on Simply Wall St. via Yahoo Finance
Institutional investors have a lot riding on EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) with 43%...
Key Insights
Institutions' substantial holdings in EyePoint Pharmaceuticals implies that they have significant influence over the company's share priceA total of 7 investors have a majority stake in the company with 50% ownership Insiders have been selling lately
To get a sense of who is truly in control of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), it is important to understand the ownership structure of the business. We can see that institutions own the lion's share in the company with 43% ownership. Put another way, the group faces the maximum upside potential (or downside risk).